Inherited long QT syndrome: phenotype and therapy to use and avoid

Clin Cardiol. 2006 Oct;29(10):429-30. doi: 10.1002/clc.4960291002.

Abstract

Patients with long QT syndrome are most commonly of three types. It is important to understand several points about this potentially lethal syndrome: 1. What precipitates the syndrome? 2. What channelopathies are involved? 3. What are the characteristic T-wave abnormalities seen in patients with long QT syndrome? 4. What therapy should be initiated? 5. Who needs an ICD? Table I summarizes several key features of the different long QT syndromes.

Publication types

  • Editorial

MeSH terms

  • Acetanilides
  • Adrenergic beta-Antagonists / therapeutic use
  • Contraindications
  • Defibrillators, Implantable
  • Drug Therapy
  • Humans
  • Long QT Syndrome* / diagnosis
  • Long QT Syndrome* / genetics
  • Long QT Syndrome* / therapy
  • Phenotype
  • Piperazines / therapeutic use
  • Ranolazine

Substances

  • Acetanilides
  • Adrenergic beta-Antagonists
  • Piperazines
  • Ranolazine